Characterization of Novel Decenoic Acid Derivatives Exhibiting Cytotoxic Activity Against T98G Glioma Cells Under a Serum- and Glucose-deprived Condition

Key Points

• Cytotoxic activity significantly reduces glioma cell viability under serum and glucose deprivation.
• The study indicates that decenoic acid derivatives effectively target T98G glioma cells in challenging conditions.
• Assessment of these compounds involved serum- and glucose-deprivation experiments to measure their efficacy.
• Findings emphasize the potential for these novel compounds in glioma treatment strategies, warranting further exploration.